Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to BURGER, JAN ANDREAS
Item TypeName
Concept Immunoglobulin A
Concept Immunoglobulin Heavy Chains
Concept Immunoglobulin Isotypes
Concept Immunoglobulin Variable Region
Concept Immunoglobulin D
Concept Immunoglobulin M
Academic Article Extramedullary plasmocytoma with local amyloidosis presenting as a lump on the lip.
Academic Article Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.
Academic Article Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Academic Article Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia
Academic Article ?2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.
Academic Article Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Academic Article The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Academic Article Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Academic Article Going through Changes: Surface IgM Levels during CLL Therapy with Ibrutinib.
Academic Article The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia.
Academic Article Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies.
Academic Article Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
Academic Article RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.
Academic Article B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.
Academic Article Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Search Criteria
  • Immunoglobulin D